Drug Information

Drug General Information
Drug ID
D05GQL
Former ID
DIB005828
Drug Name
KNI-102
Drug Type
Small molecular drug
Indication Human immunodeficiency virus infection [ICD9: 279.3; ICD10:B20-B26] Terminated [545221]
Company
Japan Energy Corp
Structure
Download
2D MOL

3D MOL
Formula
C31H41N5O7
Canonical SMILES
N1(C(=O)[C@H]([C@@H](NC(=O)[C@H](CC(=O)N)NC(=O)OCc2cccc<br />c2)Cc2ccccc2)O)[C@H](C(=O)NC(C)(C)C)CCC1
CAS Number
CAS 139694-65-8
PubChem Compound ID
65004
Target and Pathway
Target(s) HIV protease Target Info Modulator [529151]
References
Ref 545221Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800002506)
Ref 529151KNI-102, a novel tripeptide HIV protease inhibitor containing allophenylnorstatine as a transition-state mimic. Chem Pharm Bull (Tokyo). 1991 Nov;39(11):3088-90.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.